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SUMMARY During the 1998-2003 period, patch testing was carried 
out in 65 atopic dermatitis patients, 20 (31%) male and 45 (69%) 
female, mean age 34.7 (range 6-77) years. Twenty-six (40%) patients, 
7 (27%) male and 19 (73%) female, showed positive reaction to one 
or more allergens. Allergic reactions were more common in women. 
The most common allergens were nickel (33.3%), cobalt (11.1%), 
fragrance mix (11.1%), white mercury precipitate (8.4%), and others 
(36.1%). There was a significant association between nickel allergy 
and cobalt allergy. It is concluded that contact hypersensitivity is not 
rare in patients with atopic dermatitis. 
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INTRODUCTION
 Atopic dermatitis (AD) is a common chronic in-
flammatory skin disease, which generally breaks 
out in early infancy. The main characteristics of 
the disease are symptoms such as rash, vesicles, 
and itching. Family history of atopy has confirmed 
that AD must have a distinct genetic background. 
There is increased evidence for T-cell response to 
environmental allergens to play a role in the patho-
genesis of AD (1). The predominance of AD has 
increased during the past 20-30 years, its lifetime 
predominance being estimated to 10% to 15% (2). 
There are many factors including allergens, infec-
tions, emotional, climatic and other environmental 
influences that contribute to the causation of AD in 
genetically predisposed individuals (3).
 The aim of this study was to evaluate contact 
sensitivity to standard patch test allergens in AD 
patients.
SUBJECTS AND METHODS
 During the 1998-2003 period, epicutaneous 
patch testing was carried out in 65 patients, 20 
(31%) male and 45(69%) female, mean age 34.7 
(range 6-77) years, with AD meeting the criteria 
of Hanifin and Rajka (4), free of oral steroids and 
antihistamines for at least 7 days. Epicutaneous 
patch test was performed with a standard series 
of epicutaneous allergens (Table 1), obtained from 
Institute of Immunology, Zagreb, Croatia. Test sub-
stances were applied on the upper part of the pa-
tient back, on clinically uninvolved, untreated and 
non-tape stripping skin, with adhesive patch test 
strips (Curatest, Lohmann-Rauscher, Rensdorf, 
Germany). Patch test strip was removed and reac-
tion was evaluated after 48 and 72 hours. Positive 
patch test reactions were graded from + to ++++, 
according to the International Contact Dermatitis 
Research Group (ICDRG) rules (5). 
RESULTS
 Twenty-six (40%) patients, seven (27%) male 
and 19 (73%) female, showed positive reac-
tion to one or more allergens. Allergic reactions 
were more frequently found in women. The most 
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common allergen was nickel sulfate (33.3%), fol-
lowed by cobalt chloride (11.1%),  fragrance mix 
(11.1%), white mercury precipitate (8.7%), and 
others (36.1%) (Fig. 1). Concordance between 
nickel allergy and cobalt allergy was observed. All 
other allergens showed lower predominance on 
patch testing.
DISCUSSION
 Positive epicutaneous patch test reactions in 
AD patients are reported. There is no doubt that 
patients with AD can acquire allergic contact sen-
sitization and often need to be patch tested (6,7). 
Patch-test results from 9 countries (2322 patients 
with AD predisposition and 2126 matched controls) 
were retrospectively evaluated. All patients were 
tested with nickel sulfate, fragrance mix, potas-
sium dichromate, lanolin alcohol, formaldehyde, 
and mercury ammonium chloride (at correspond-
ing dilutions and vehicles). As expected, compared 
to matched controls, patients with a predisposition 
to AD tended to have more suspect and irritant re-
actions on the first day. As a new observation, it 
turned out that less reactions of a crescendo pat-
tern and stronger reactions were observed on the 
third day. All differences were statistically nonsig-
nificant (8).
 In a total of 410 subjects, 197(48%) were diag-
nosed with relevant allergic contact dermatitis af-
ter extensive patch testing. In 148 (36%) subjects 
all patch tests were negative, whereas 189 (46%) 
were atopic. Among 189 atopic subjects, 102 
(54%) had relevant contact allergy. This percent-
age exceeded 45% of non-atopics with allergic 
contact dermatitis. The percentage of atopics with 
irritant reactions (22%) was not different from non-
atopics (20%). These findings highlight the need 
of careful surveillance of patch tests using well-
defined parameters to distinguish irritant reactions 
from relevant contact allergic reactions (9).
 Lamintausta et al. studied 851 AD patients di-
vided according to age groups into group 1 aged 
28-41 and group 2 aged 19-27. The frequency 
of positive patch test reactions varied between 
patient groups from 25% to 67%. The frequency 
among older AD patients was slightly higher (57%) 
in comparison with the younger group (42%). 
Those AD patients who had a longer history of se-
vere symptoms developed positive reactions most 
often (67%) (10).
 According to the literature, the occurrence of 
contact allergy among AD patients ranges beetwen 
0.1% and 57% (11-14), depending on the popula-
tion tested and the allergen used (10). De Groot 
used European standard series to study 214 AD 
patients, and found 37% of atopic subjects to have 
at least one positive patch test reaction (15).
 In 73 adult AD patients tested, Lever and For-
syth recorded one or more positive patch test re-
action in 31 (42%) patients. The most common 
Allergen Dilution (%) vehicle     Allergen Dilution (%) vehicle
1 Potassium dichromate     0.5 petrolatum 12 PPD-black rubber mix  0.1 petrolatum
2 Cobalt chloride  1.0     ¨ 13 Thiuram mix  1.0      ¨
3 Nickel sulfate  5.0     ¨ 14 Carba mix  3.0      ¨
4 Fragrance mix  8.0     ¨ 15 Wood tars 12.0     ¨
5 p-paraphenylenediamine  0.5     ¨ 16 Neomycin sulfate 20.0     ¨
6 Balsam of Peru  25.0   ¨ 17 Parabene mix 15.0     ¨
7 Epoxy resin  1.0     ¨ 18 Lanolin alcohol 30.0     ¨
8 Colophony 20.0    ¨ 19 Formaldehyde  1.0 water
9 White mercury      
   precipitate  
10.0    ¨ 20 Detergent  2.0        ¨
10 Benzocaine  5.0     ¨ 21 Thimerosal  0.1 petrolatum
11 Mercapto mix  2.0     ¨ 22 Petrolatum   As it is
Table 1. Standard series of allergens used in patch testing
Figure 1. Results of patch testing in atopic derma-
titis patients
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allergens were fragrances in 13, nickel in 7, rubber 
in 5, lanolin in 4, and formaldehyde in 3 patients 
(6).
 Our results on 40% positive patch test reactions 
in AD patients have confirmed those from a previ-
ous study, that AD patients often become sensitive 
to contact allergens. The most common allergen 
was nickel sulfate (10,16), followed by cobalt chlo-
ride (17). Cobalt allergy was also more frequently 
observed in women, and was often associated 
with nickel allergy (18), as in our patients. The 
persons with atopy showed altered cell-mediated 
immunity and therefore a decreased capacity to 
develop contact allergy. This trend has particularly 
been proposed for severe AD patients (14). Con-
tact sensitization is frequent among AD patients. 
Thus patch testing is highly warranted during the 
course of the disease. The number of patch test 
reactions increased with age (10).
 In AD patients, positive contact allergens pen-
etrate the epidermal skin barrier more easily due 
to its lipid barrier lesion. These allergens include 
nickel, latex, vehicle of external preparations, fra-
grances, etc. Furthemore, irritant agents such as 
wool or disinfectants might lead to some exac-
erbation of the disease. Therefore, avoidance or 
even reduction of these factors in the environment 
should be one of the basic principles in the man-
agement of the disease (19).
References
1. Cooper KD. Atopic dermatitis; recent trends in 
pathogenesis and therapy. J Invest Dermatol 
1994;102:128-35.
2. Engler RJ, Kenner J, Leung DY. Smallpox 
vaccination: risk consideration for patients 
with atopic deramtitis. J Allergy Clin Immunol 
2002;110:357-65.
3. Friedmann PS. The role of dust mite antigen 
sensitization and atopic dermatitis. Clin Exp 
Allergy 1999;29:869-72.        
4. Hanifin JM, Rajka G. Diagnostic features of 
atopic dermatitis. Acta Derm Venereol (Stockh) 
1980;114:146-8.                                               
 5. Hjorth DS, Fregert S. Contact dermatitis. In: 
Rook A, Willkinson DS, Ebling FJG, eds. Text-
book of dermatology. 3rd ed. Oxford: Blackwell; 
1984. p. 363-484.
6. Lever R, Forsyth A. Allergic contact dermati-
tis in atopic dermatitis. Acta Derm Venereol 
(Stockh) 1992;176:95-8.
7. Cronin E, McFadden JP. Patients with atopic 
eczema do become sensitive to contact aller-
gens. Contact Dermatitis 1993;28:225-8.
8. Brasch J, Schnuch A, Uter W. Patch-test reac-
tion in patient predisposition to atopic dermati-
tis. Contact Dermatitis 2003;49:197-201.
9. Klas PA, Corey G, Stoors FJ, Chan SC, Hani-
fin MJ. Allergic and irritant patch test reac-
tions in atopic disease. Contact Dermatitis 
1996;34:121-4.
10. Laminitausta K, Kalimo K, Fagerlund VL. 
Patch test reactions in atopic patients. Contact 
Dermatitis 1992;26:234-40.
11. Bandmann HJ, Breit R, Leutgeb C. Kontak-
tallergie und Dermatitis atopica. Arch  Invest 
Dermatol 1972;244:332-9.  
12. Jones HE, Lewis CW, McMartin MSL. Allergic 
contact sensitivity in atopic dermatitis. Arch 
Dermatol 1973;107:217-22.
13. Rystedt I. Contact sensitivity in adults with 
atopic dermatitis in childhood. Contact Der-
matitis 1985;13:1-8.
14. Uehara M, Sawwai T. A longitudinal study of 
contact sensitivity in patients with atopic der-
matitis. Arch Dermatol 1985;125:366-8. 
15. De Groot AC. The frequency of contact allergy 
in atopic patients with dermatitis. Contact Der-
matitis 1990;22:273-7.
16. Lipozenčić J, Glavaš B. Characterization of 
patch test reaction in atopic dermatitis pa-
tients. Acta Dermatovenerol Croat 1996;4:53-
8.
17. Morghescu S. Patch test reactions in atop-
ic patients. Acta Derm Venereol (Stockh) 
1985;144:113-6.
18. Dotterud LK, Falk ES. Contact allergy in re-
alation to hand eczema and atopic disease in 
north Norwegian school children. Acta Pediatr 
1995;84:402-6.
19. Meagher LJ, Wines NY, Cooper AJ. Atopic 
dermatitis: review of immunopathogenesis 
and advances in immunosuppresive therapy. 
Australas J Dermatol 2002;43:247-54.
Kuljanac et al.     Acta Dermatovenerol Croat
Patch test in atopic dermatitis                    2005;13(4):225-227
